Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

4.100 +0.040 (+0.99%)

Streaming Delayed Price Updated: 9:33 AM EST, Dec 3, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,313
Open	4.060
Bid (Size)	4.050 (1,000)
Ask (Size)	4.130 (500)
Prev. Close	4.060
Today's Range	4.060 - 4.100
52wk Range	3.030 - 9.305
Shares Outstanding	16,425,036
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer

November 14, 2025

From Sensus Healthcare, Inc.

Via Business Wire

Sensus Healthcare Appoints Eric Sachetta to its Board of Directors

November 12, 2025

From Sensus Healthcare, Inc.

Via Business Wire

Performance

YTD	-42.3%	-42.3%
1 Month	+32.3%	+32.3%
3 Month	+21.3%	+21.3%
6 Month	-15.1%	-15.1%
1 Year	-52.1%	-52.1%

More News

Sensus SRTS Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Via The Motley Fool

Sensus Healthcare Inc (NASDAQ:SRTS) Beats Q3 2025 Earnings Estimates Despite Revenue Decline ↗

November 06, 2025

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Sensus Healthcare Reports Third Quarter 2025 Financial Results

November 06, 2025

From Sensus Healthcare, Inc.

Via Business Wire

Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026

November 06, 2025

From Sensus Healthcare, Inc.

Via Business Wire

CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer

November 04, 2025

From Sensus Healthcare, Inc.

Via Business Wire

Sensus Healthcare Announces the Passing of Director Bill McCall

October 31, 2025

From Sensus Healthcare, Inc.

Via Business Wire

Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6

October 23, 2025

From Sensus Healthcare, Inc.

Via Business Wire

SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders

October 09, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids

September 23, 2025

From Sensus Healthcare, Inc.

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

September 14, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

September 10, 2025

From Pomerantz LLP

Via GlobeNewswire

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

September 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

September 06, 2025

From Pomerantz LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm

September 04, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

September 02, 2025

From Pomerantz LLP

Via GlobeNewswire

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

August 31, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

August 29, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

August 25, 2025

From Pomerantz LLP

Via GlobeNewswire

SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm

August 24, 2025

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

August 21, 2025

From Pomerantz LLP

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 08, 2025

Via Benzinga

Frequently Asked Questions

Is Sensus Healthcare, Inc. - Common Stock publicly traded?

Yes, Sensus Healthcare, Inc. - Common Stock is publicly traded.

What exchange does Sensus Healthcare, Inc. - Common Stock trade on?

Sensus Healthcare, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sensus Healthcare, Inc. - Common Stock?

The ticker symbol for Sensus Healthcare, Inc. - Common Stock is SRTS on the Nasdaq Stock Market

What is the current price of Sensus Healthcare, Inc. - Common Stock?

The current price of Sensus Healthcare, Inc. - Common Stock is 4.100

When was Sensus Healthcare, Inc. - Common Stock last traded?

The last trade of Sensus Healthcare, Inc. - Common Stock was at 12/03/25 09:33 AM ET

What is the market capitalization of Sensus Healthcare, Inc. - Common Stock?

The market capitalization of Sensus Healthcare, Inc. - Common Stock is 67.34M

How many shares of Sensus Healthcare, Inc. - Common Stock are outstanding?

Sensus Healthcare, Inc. - Common Stock has 67M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.